Ascent Solar Technologies, Inc. (NASDAQ:ASTI), which makes lightweight, flexible copper indium gallium diselenide (CIGS) thin-film photovoltaic modules that it integrates into its EnerPlex series of consumer products, has announced availability of its EnerPlex Jumpr Slate at company-owned kiosks, as well as online. The product will be available at partner retailers both domestically and internationally later in April. Ascent Solar Technologies, Inc. (NASDAQ:ASTI) stock performance was 9.30% in last session and finished the day at $0.481. Traded volume was 518,206.00million shares in the last session and the average volume of the stock remained 623.43K shares. The beta of the stock remained 2.47. Ascent Solar Technologies, Inc. (NASDAQ:ASTI) insider ownership is 2.10%.

Spherix Inc (NASDAQ:SPEX) has reportedly sued Cisco over allegations of patent infringement by Cisco of 11 patents owned by Spherix Inc (NASDAQ:SPEX), which it had acquired from Nortel Networks. Spherix Inc (NASDAQ:SPEX) contends that the patent infringements undertaken by Cisco account for its earnings equivalent to $43 billion, which in earned through its sales of switches and routers in the U.S. Spherix Inc (NASDAQ:SPEX) dropped -4.49 percent to $1.70 Monday on volume of 392,262.00million shares. The intra-day range of the stock was $1.62 to $1.88. Spherix Inc (NASDAQ:SPEX) has a market capitalization of $13.34million.

Bothell-based BioLife Solutions Inc (NASDAQ:BLFS) announced April 21 that it was added to the Wilshire 5000 Total Market Index effective after the markets close on April 18 in conjunction with the monthly additions and deletions of the index. BioLife Solutions Inc (NASDAQ:BLFS)’s stock on Apr 28, 2014 reported a decrease of -5.74% to the closing price of $3.12. Its fifty two weeks range is $3.09 -$23.94. The total market capitalization recorded $37.26million. The overall volume in the last trading session was 51,881.00million shares. In its share capital, BLFS has 11.93million outstanding shares.

Small cap CollabRx Inc (NASDAQ: CLRX), which delivers content knowledge-based products and services to help with healthcare decision-making, recently announced what could be a key agreement with diagnostic company Affymetrix, Inc (NASDAQ: AFFX) to deal with cancer information overload meaning its time to take a closer look at the company, the new deal and the performance of some potential benchmarks likeWebMD Health Corp (NASDAQ: WBMD) and The Advisory Board Company (NASDAQ: ABCO). On Monday, shares of CollabRx Inc (NASDAQ:CLRX) dropped -5.67% to close the day at $2.83. Company return on investment (ROI) is -70.20% and its monthly performance is recorded as -11.84%. CollabRx Inc (NASDAQ:CLRX) quarterly revenue growth is -22.68%.